Pancreatic Cancer Research

ResearcherNankai UniversityNo recent work listed

Beibei Xin

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 3 papers · 2017: 2 papers · 2018: 1 paper

Papers 6

  1. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling. Co-author DOI 10.1016/j.yexcr.2018.02.008↗
  2. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells. Co-author DOI 10.1002/cbf.3278↗
  3. Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer. Co-author DOI 10.18632/oncotarget.20160↗
  4. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer. Co-author DOI 10.1016/j.pan.2016.09.005↗
  5. Gastrin regulates ABCG2 to promote the migration, invasion and side populations in pancreatic cancer cells via activation of NF-κB signaling. First author DOI 10.1016/j.yexcr.2016.06.001↗
  6. Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells. Co-author DOI 10.1080/15384047.2016.1139228↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaohong Shen · 6 shared papers, 2016–2018 · strength 0.43
  2. Jun Cai · 4 shared papers, 2016–2018 · strength 0.29
  3. Shaoxia Du · 3 shared papers, 2017–2018 · strength 0.23
  4. Hui Wang · 3 shared papers, 2017–2018 · strength 0.23
  5. Juan Wang · 3 shared papers, 2016–2018 · strength 0.22
  6. Xiaodan He · 3 shared papers, 2016 · strength 0.20
  7. Wei Wei · 2 shared papers, 2016–2017 · strength 0.14
  8. Meiyan Shi · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.